Philips and Spanish Hospital Campus de la Salud Start Implementation of Multi-Year Strategic Partnership Agreement

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the successful start of a long-term strategic partnership with Servicio Andaluz de Salud (Andalusian Health Service, Spain). The partnership, which includes an eight year, EUR 77 million managed equipment services agreement, will make the newly built Clinical Hospital at the Granada Health Science Technological Park (PTS) the most technologically advanced health center serving patients in the Andalusia region of Spain.

Under the terms of the agreement, which is the largest of its kind in Andalusia and one of the largest in Spain, Philips is providing Campus de la Salud Hospital with a technology management model to meet its current and future healthcare needs, while also taking responsibility for the maintenance, upgrading and renewal of the equipment and systems until 2024. With more than 90% of the hospital's equipment being renewed, over 900,000 people in the region served by Campus de la Salud will now have access to the most up-to-date technologies to aid in the diagnosis, treatment and monitoring of their clinical conditions.

Today also marks the transfer of existing in-patients to the hospital’s brand new clinical care units. Philips solutions now available to them include Spain's first fully digital pathology laboratory, equipped with Philips' advanced digital pathology solutions, including a state-of-the-art digital pathology image management system and innovative data analytics. Other equipment being installed by Philips will include a 3T MRI scanner, four CT systems and two systems for image-guided minimally-invasive therapies, to enhance the treatment of cardiovascular diseases and cancer. Patients and care providers will also enjoy the benefits of advanced clinical information and patient monitoring systems. At the same time the hospital staff will have access to integrated connected care solutions that improve workflows and optimize utilization of the hospital's resources.

"In collaboration with the healthcare industry, Philips is committed to creating the scale and integration needed for a global sustainable approach to healthcare delivery," said Juan Sanabria, Market Leader of Philips Ibérica. "Combined with our deep clinical and consumer domain expertise, we are uniquely positioned to enable transformative solutions that translate into real solutions for consumers and customers alike."

The strategic partnership also includes a framework agreement for joint research in key areas of healthcare, as well as the training of professionals in new technologies and clinical procedures. As part of this framework agreement, Philips will make the new PTS hospital campus a benchmark for joint research projects in various areas of health, including clinical research and improvement of care processes.

As a pioneer, Philips has been implementing more than 40 of these long-term, strategic partnerships globally. Recent examples include partnerships with Westchester Medical Center Health (US), Marin County Hospital (US), Heart Hospital Tampare (Finland) and Karolinska Hospital (Sweden). In Spain, Philips has similar partnerships with the Santa Creu I Sant Pau Hospital and the University and Polytechnic Hospital La Fe in Valencia. These collaborations are based on a managed equipment services model through which hospitals have access to state-of-the art equipment (including those of other vendors) and services for a multi-year term under a single payment structure. This includes procurement, installation, systems integration, maintenance, timely updates and research to ensure that the hospitals involved are provided with the medical technologies that their departments require for the optimal delivery of care.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 105,000 employees with sales and services in more than 100 countries.

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...